Capecitabine‐containing regimens vs chemotherapy regimens without capecitabine
Diarrhoea · neoadjuvant treatment of ER‐positive vs ER‐negative breast cancer
Capecitabine‐containing regimens probably leads to higher diarrhoea compared with non‐capecitabine‐containing regimens (moderate certainty).
1 finding from 1 review
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes onlyOR 1.95 [1.32, 2.89]3 studies · 2686 participantsModerate